Blog
Heidi Hancock Strunk joins the Pearl Pathways Team
Pearl Pathways is pleased to announce the hiring of Heidi Hancock Strunk, RAC as a Regulatory Compliance Advisor. Strunk brings over twenty-three years of experience in FDA-regulated industries and thirteen years in management, including extensive expertise in the...
New forms and resources for IRB submissions on the Pearl IRB website
We are pleased to announce our recent updates to the Pearl IRB website. In the Resources section, you will find new and revised forms to serve you in the IRB submission process. Some of these changes include: Updated submission guide and policies, which we suggest all...
New study reveals notable improvement in public perception of clinical trials
inVentiv Clinical Trial Recruitment Solutions (iCTRS) shared good news in a recent article posted on dddmag.com regarding perceptions of potential clinical trial participants.. The Center for Information and Study on Clinical Research Participation (CISCRP) conducted...
Drug companies seek more clinical trial volunteers
Among the many obstacles drug companies face in bringing a product to market, recruiting clinical trial volunteers has become increasingly difficult, according to a recent article on www.washingtonpost.com by Lenny Bernstein. Bernstein states that more than 10% of...
FDA releases final guidance on transfer of IRB oversight
FDA has issued final guidance concerning the transfer of clinical studies between IRBs. According to Zachary Brennan on www.outsourcing-pharma.com, FDA says the transfer process “should be accomplished in a way that assures continuous IRB oversight with no lapse in...